These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

662 related articles for article (PubMed ID: 15047839)

  • 1. Early activation of the Kaposi's sarcoma-associated herpesvirus RTA, RAP, and MTA promoters by the tetradecanoyl phorbol acetate-induced AP1 pathway.
    Wang SE; Wu FY; Chen H; Shamay M; Zheng Q; Hayward GS
    J Virol; 2004 Apr; 78(8):4248-67. PubMed ID: 15047839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CCAAT/enhancer-binding protein-alpha is induced during the early stages of Kaposi's sarcoma-associated herpesvirus (KSHV) lytic cycle reactivation and together with the KSHV replication and transcription activator (RTA) cooperatively stimulates the viral RTA, MTA, and PAN promoters.
    Wang SE; Wu FY; Yu Y; Hayward GS
    J Virol; 2003 Sep; 77(17):9590-612. PubMed ID: 12915572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of CCAAT/enhancer-binding protein alpha (C/EBPalpha) in activation of the Kaposi's sarcoma-associated herpesvirus (KSHV) lytic-cycle replication-associated protein (RAP) promoter in cooperation with the KSHV replication and transcription activator (RTA) and RAP.
    Wang SE; Wu FY; Fujimuro M; Zong J; Hayward SD; Hayward GS
    J Virol; 2003 Jan; 77(1):600-23. PubMed ID: 12477864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell cycle arrest by Kaposi's sarcoma-associated herpesvirus replication-associated protein is mediated at both the transcriptional and posttranslational levels by binding to CCAAT/enhancer-binding protein alpha and p21(CIP-1).
    Wu FY; Wang SE; Tang QQ; Fujimuro M; Chiou CJ; Zheng Q; Chen H; Hayward SD; Lane MD; Hayward GS
    J Virol; 2003 Aug; 77(16):8893-914. PubMed ID: 12885907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patterns of gene expression and a transactivation function exhibited by the vGCR (ORF74) chemokine receptor protein of Kaposi's sarcoma-associated herpesvirus.
    Chiou CJ; Poole LJ; Kim PS; Ciufo DM; Cannon JS; ap Rhys CM; Alcendor DJ; Zong JC; Ambinder RF; Hayward GS
    J Virol; 2002 Apr; 76(7):3421-39. PubMed ID: 11884567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct interactions of Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 ORF50/Rta protein with the cellular protein octamer-1 and DNA are critical for specifying transactivation of a delayed-early promoter and stimulating viral reactivation.
    Carroll KD; Khadim F; Spadavecchia S; Palmeri D; Lukac DM
    J Virol; 2007 Aug; 81(16):8451-67. PubMed ID: 17537858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of Novel Kaposi's Sarcoma-Associated Herpesvirus Orf50 Transcripts: Discovery of New RTA Isoforms with Variable Transactivation Potential.
    Wakeman BS; Izumiya Y; Speck SH
    J Virol; 2017 Jan; 91(1):. PubMed ID: 27795414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative study of regulation of RTA-responsive genes in Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8.
    Song MJ; Deng H; Sun R
    J Virol; 2003 Sep; 77(17):9451-62. PubMed ID: 12915560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ERK1/2 and MEK1/2 induced by Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) early during infection of target cells are essential for expression of viral genes and for establishment of infection.
    Sharma-Walia N; Krishnan HH; Naranatt PP; Zeng L; Smith MS; Chandran B
    J Virol; 2005 Aug; 79(16):10308-29. PubMed ID: 16051824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ARID3B: a Novel Regulator of the Kaposi's Sarcoma-Associated Herpesvirus Lytic Cycle.
    Wood JJ; Boyne JR; Paulus C; Jackson BR; Nevels MM; Whitehouse A; Hughes DJ
    J Virol; 2016 Oct; 90(20):9543-55. PubMed ID: 27512077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcriptional regulation of the open reading frame 35 encoded by Kaposi's sarcoma-associated herpesvirus.
    Masa SR; Lando R; Sarid R
    Virology; 2008 Feb; 371(1):14-31. PubMed ID: 17963810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Global changes in Kaposi's sarcoma-associated virus gene expression patterns following expression of a tetracycline-inducible Rta transactivator.
    Nakamura H; Lu M; Gwack Y; Souvlis J; Zeichner SL; Jung JU
    J Virol; 2003 Apr; 77(7):4205-20. PubMed ID: 12634378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 ORF50 deletion mutant is defective for reactivation of latent virus and DNA replication.
    Xu Y; AuCoin DP; Huete AR; Cei SA; Hanson LJ; Pari GS
    J Virol; 2005 Mar; 79(6):3479-87. PubMed ID: 15731242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of the kaposi's sarcoma-associated herpesvirus transactivator K-Rta can complement a K-bZIP deletion BACmid and yields an enhanced growth phenotype.
    Kato-Noah T; Xu Y; Rossetto CC; Colletti K; Papouskov√° I; Pari GS
    J Virol; 2007 Dec; 81(24):13519-32. PubMed ID: 17913803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of the NEDD8-Activating Enzyme Inhibitor MLN4924 on Lytic Reactivation of Kaposi's Sarcoma-Associated Herpesvirus.
    Chang PJ; Chen LW; Chen LY; Hung CH; Shih YJ; Wang SS
    J Virol; 2017 Oct; 91(19):. PubMed ID: 28701396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Convergence of Kaposi's sarcoma-associated herpesvirus reactivation with Epstein-Barr virus latency and cellular growth mediated by the notch signaling pathway in coinfected cells.
    Spadavecchia S; Gonzalez-Lopez O; Carroll KD; Palmeri D; Lukac DM
    J Virol; 2010 Oct; 84(20):10488-500. PubMed ID: 20686042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptional downregulation of ORF50/Rta by methotrexate inhibits the switch of Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 from latency to lytic replication.
    Curreli F; Cerimele F; Muralidhar S; Rosenthal LJ; Cesarman E; Friedman-Kien AE; Flore O
    J Virol; 2002 May; 76(10):5208-19. PubMed ID: 11967335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of Kaposi's sarcoma-associated herpesvirus (KSHV) by inhibitors of class III histone deacetylases: identification of sirtuin 1 as a regulator of the KSHV life cycle.
    Li Q; He M; Zhou F; Ye F; Gao SJ
    J Virol; 2014 Jun; 88(11):6355-67. PubMed ID: 24672028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of tetradecanoyl phorbol acetate-induced lytic reactivation of Kaposi's sarcoma-associated herpesvirus by K1 signal transduction.
    Lee BS; Paulose-Murphy M; Chung YH; Connlole M; Zeichner S; Jung JU
    J Virol; 2002 Dec; 76(23):12185-99. PubMed ID: 12414958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular corepressor TLE2 inhibits replication-and-transcription- activator-mediated transactivation and lytic reactivation of Kaposi's sarcoma-associated herpesvirus.
    He Z; Liu Y; Liang D; Wang Z; Robertson ES; Lan K
    J Virol; 2010 Feb; 84(4):2047-62. PubMed ID: 19939918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.